E2 ModerateModerate confidencePEM not requiredCase-ControlPeer-reviewedMachine draft
Clinical and neurocognitive features of the post Lyme syndrome.
Bujak, D I, Weinstein, A, Dornbush, R L · The Journal of rheumatology · 1996
Quick Summary
This study looked at people who had Lyme disease and continued to have fatigue, joint pain, and memory problems even after antibiotic treatment. Researchers compared 23 of these patients to 23 people who recovered fully from Lyme disease. The group with ongoing symptoms performed worse on memory and concentration tests, reported more sleep and mood problems, and showed signs of greater emotional distress.
Why It Matters
This study is relevant to ME/CFS research because it documents persistent neurocognitive impairment following a documented infectious trigger (Lyme disease) despite standard treatment—a pattern that mirrors post-infectious ME/CFS. The finding that objective cognitive deficits accompany subjective complaints validates patient-reported cognitive dysfunction and supports the biological basis of post-infectious fatigue syndromes.
Observed Findings
- 22 of 23 (96%) PLS patients reported memory or concentration complaints compared to controls
- PLS patients had significantly lower attention/concentration scores on the Wechsler Memory Scale-Revised (p=0.012)
- 52% of PLS patients showed significantly lower verbal than visual memory scores, versus 35% in the recovered group (p<0.05)
- PLS patients reported significantly more sleep problems and mood changes than recovered controls (p<0.01)
- PLS patients had significantly higher SCL-90-R physical distress scores and Beck Depression Inventory scores than controls (p<0.01 and p<0.005 respectively, though scores remained in normal range)
Inferred Conclusions
- Persistent neurocognitive impairment can follow Lyme disease even after standard antibiotic treatment, suggesting post-Lyme syndrome represents a true post-infectious sequela
- Attention and concentration deficits in PLS are measurable on objective neuropsychological testing, not merely subjective complaints
- PLS overlaps with but is not identical to fibromyalgia and chronic fatigue syndrome, though 43% of patients had features of both conditions
Remaining Questions
- What mechanisms explain persistent neurocognitive deficits despite microbiological cure—immune dysregulation, persistent infection, or other pathophysiology?
What This Study Does Not Prove
This study does not prove that all ME/CFS cases originate from Lyme disease or respond similarly to Lyme-specific mechanisms. It cannot establish causation for the cognitive deficits or determine whether they result from persistent infection, immune dysfunction, or other post-infectious processes. The study's cross-sectional design cannot characterize whether neurocognitive deficits improve, stabilize, or worsen over time.
Tags
Symptom:Cognitive DysfunctionUnrefreshing SleepPainFatigue
Phenotype:Infection-Triggered
Method Flag:PEM Not DefinedWeak Case DefinitionSmall SampleMixed Cohort
Metadata
- PMID
- 8856619
- Review status
- Machine draft
- Evidence level
- Single-study or moderate support from human research
- Last updated
- 8 April 2026
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Spotted an error in this entry? Report it →